AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis

Autor: Seishi Ogawa, Tetsuya Yamagata, Toshiki Saito, Ieharu Yamazaki, Sachiko Seo, Shigeru Chiba, Motoshi Ichikawa, Kinuko Mitani, Mineo Kurokawa, Hisamaru Hirai, Takashi Asai, Go Yamamoto
Rok vydání: 2004
Předmět:
Zdroj: Nature Medicine. 10:299-304
ISSN: 1546-170X
1078-8956
Popis: Embryonic development of multilineage hematopoiesis requires the precisely regulated expression of lineage-specific transcription factors, including AML-1 (encoded by Runx1; also known as CBFA-2 or PEBP-2αB)1,2,3,4,5. In vitro studies and findings in human diseases, including leukemias6,7, myelodysplastic syndromes8 and familial platelet disorder with predisposition to acute myeloid leukemia (AML)9, suggest that AML-1 has a pivotal role in adult hematopoiesis. However, this role has not been fully uncovered in vivo because of the embryonic lethality of Runx1 knockout in mice. Here we assess the requirement of AML-1/Runx1 in adult hematopoiesis using an inducible gene-targeting method10. In the absence of AML-1, hematopoietic progenitors were fully maintained with normal myeloid cell development. However, AML-1-deficient bone marrow showed inhibition of megakaryocytic maturation, increased hematopoietic progenitor cells and defective T- and B-lymphocyte development. AML-1 is thus required for maturation of megakaryocytes and differentiation of T and B cells, but not for maintenance of hematopoietic stem cells (HSCs) in adult hematopoiesis.
Databáze: OpenAIRE